Skip to main content

Tyme Technologies, Inc.

TYMEDelisted Sep 16, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001537917

Tyme Technologies, Inc. was delisted on Sep 16, 2022; its insiders filed their last Form 4 on Sep 16, 2022; 56 institutions reported holding it in 13F filings for Q2 2022, worth $3.07M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Tyme Technologies, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Tyme Technologies, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Tyme Technologies, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Tyson TimothyDirector0Sep 16, 20220
Michels Douglas ADirector0Sep 16, 20220
Carberry DavidDirector0Sep 16, 20220
DeGolyer Donald WDirector–Sep 16, 20220
Cunningham, Richard AnthonyChief Executive Officer–Sep 16, 20220
Biehl JamesChief Legal Officer0IndirectSep 16, 20220
Hoffman SteveDirector, 10% Owner0Sep 16, 20220
Sokol Gerald HDirector0Sep 16, 20220
Eckard JonathanChief Business Officer–Sep 16, 20220
Galaini BarbaraSee remarks0Sep 16, 20220
Baker Christine D.Director–Sep 16, 20220
Porfido Frank L.Chief Financial Officer0Sep 16, 20220
Demurjian Michael10% Owner22,448,846Sep 7, 20220
Van Tornout Jan MActing Chief Medical Officer9,831Apr 26, 20220
Sturman Paul LDirector–Aug 26, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 29, 2021 (view filing)Nov 227 daysLateDemurjian Michael10% OwnerSSale−9.38K$0.80−$7.50K0.0%24.1M after
Nov 18, 2021 (view filing)Nov 171 dayDemurjian Michael10% OwnerSSale−20.0K$0.91−$18.2K−0.1%24.1M after
Nov 17, 2021 (view filing)Nov 15-162 daysHoffman SteveChief Science OfficerSSale−156.3K$0.92−$143.8K−0.7%22.4M after2 lots
Nov 15, 2021 (view filing)Nov 123 daysGalaini BarbaraSee RemarksPPurchase+10.0K$0.95+$9.50K+100.0%20.0K after
Nov 15, 2021 (view filing)Nov 123 daysBiehl JamesChief Legal OfficerPPurchase+10.0K$0.95+$9.50K+15.4%75.0K after
Nov 15, 2021 (view filing)Nov 123 daysPorfido Frank L.Chief Financial OfficerPPurchase+10.0K$0.93+$9.30KNew position10.0K after
Nov 8, 2021 (view filing)Nov 8Same dayDemurjian Michael10% OwnerSSale−20.0K$1.00−$20.0K−0.1%24.1M after
Nov 5, 2021 (view filing)Nov 32 daysDemurjian Michael10% OwnerSSale−20.0K$1.00−$20.0K−0.1%24.1M after
Oct 29, 2021 (view filing)Oct 29Same dayDemurjian Michael10% OwnerSSale−20.0K$0.95−$19.0K−0.1%24.1M after
Oct 28, 2021 (view filing)Oct 26-272 daysHoffman SteveChief Science OfficerSSale−156.3K$0.965−$150.8K−0.7%22.5M after2 lots
Oct 22, 2021 (view filing)Oct 202 daysDemurjian Michael10% OwnerSSale−20.0K$0.97−$19.4K−0.1%24.2M after
Oct 14, 2021 (view filing)Oct 131 dayDemurjian Michael10% OwnerSSale−20.0K$1.00−$20.0K−0.1%24.2M after
Oct 6, 2021 (view filing)Oct 4-52 daysHoffman SteveChief Science OfficerSSale−156.3K$1.00−$156.3K−0.7%22.7M after2 lots
Oct 4, 2021 (view filing)Oct 4Same dayDemurjian Michael10% OwnerSSale−20.0K$1.00−$20.0K−0.1%24.2M after
Sep 28, 2021 (view filing)Sep 271 dayDemurjian Michael10% OwnerSSale−20.0K$1.12−$22.4K−0.1%24.2M after
Sep 23, 2021 (view filing)Sep 221 dayCarberry DavidDirectorPPurchase+50.0K$1.03+$51.5K+100.0%100.0K afterDuplicate filing
Sep 23, 2021 (view filing)Sep 221 dayCarberry DavidDirectorPPurchase+50.0K$1.03+$51.5K+100.0%100.0K after
Sep 21, 2021 (view filing)Sep 201 dayDemurjian Michael10% OwnerSSale−20.0K$1.01−$20.2K−0.1%24.2M after
Sep 17, 2021 (view filing)Sep 152 daysHoffman SteveChief Science OfficerSSale−172.8K$1.03−$178.0K−0.8%22.8M after2 lots
Sep 13, 2021 (view filing)Sep 13Same dayDemurjian Michael10% OwnerSSale−20.0K$1.04−$20.8K−0.1%24.3M after
Sep 7, 2021 (view filing)Sep 7Same dayDemurjian Michael10% OwnerSSale−20.0K$1.12−$22.4K−0.1%24.3M after
Sep 3, 2021 (view filing)Sep 1-22 daysHoffman SteveChief Science OfficerSSale−249.5K$1.14−$285.3K−1.1%23.0M after2 lots
Sep 1, 2021 (view filing)Aug 302 daysDemurjian Michael10% OwnerSSale−20.0K$1.10−$22.0K−0.1%24.3M after
Aug 27, 2021 (view filing)Aug 25-262 daysHoffman SteveChief Science OfficerSSale−156.3K$1.08−$168.8K−0.7%23.3M after2 lots
Aug 24, 2021 (view filing)Aug 231 dayDemurjian Michael10% OwnerSSale−20.0K$1.03−$20.6K−0.1%24.3M after
Aug 17, 2021 (view filing)Aug 161 dayDemurjian Michael10% OwnerSSale−20.0K$1.02−$20.4K−0.1%24.3M after
Aug 16, 2021 (view filing)Aug 124 daysVan Tornout Jan MActing Chief Medical OfficerPPurchase+1.00K$1.05+$1.05K+55.3%2.81K after
Aug 10, 2021 (view filing)Aug 91 dayDemurjian Michael10% OwnerSSale−20.0K$1.15−$23.0K−0.1%24.4M after
Aug 5, 2021 (view filing)Aug 3-42 daysHoffman SteveChief Science OfficerSSale−178.7K$1.10−$196.8K−0.8%23.4M after2 lots
Aug 3, 2021 (view filing)Aug 21 dayDemurjian Michael10% OwnerSSale−20.0K$1.15−$23.0K−0.1%24.4M after
Aug 2, 2021 (view filing)Jul 29-304 daysHoffman SteveChief Science OfficerSSale−244.2K$1.18−$288.6K−1.0%23.6M after2 lots
Jul 27, 2021 (view filing)Jul 261 dayDemurjian Michael10% OwnerSSale−20.0K$1.53−$30.6K−0.1%24.4M after
Jul 22, 2021 (view filing)Jul 20-212 daysHoffman SteveChief Science OfficerSSale−156.3K$1.07−$167.2K−0.7%23.8M after2 lots
Jul 19, 2021 (view filing)Jul 19Same dayDemurjian Michael10% OwnerSSale−20.0K$1.02−$20.4K−0.1%24.4M after
Jul 12, 2021 (view filing)Jul 12Same dayDemurjian Michael10% OwnerSSale−20.0K$1.16−$23.2K−0.1%24.4M after
Jul 6, 2021 (view filing)Jul 6Same dayDemurjian Michael10% OwnerSSale−20.0K$1.18−$23.6K−0.1%24.5M after